FASN and Insulin resistance: In addition, omega-3 fatty acids through decreasing gene expression of fatty acid synthase (FAS), and phosphoenolpyruvate carboxykinase (PEPCK), reducing insulin resistance and inhibiting the inflammatory pathways triggered by cytokines can improve cardiometabolic risk [17, 21, 38–40].